← Back
$SLDB All transactions

Solid Biosciences Inc.

M

$ Value

Shares

9,750

Price

Filed

Oct 21

Insider

Name

Brooks Gabriel

Title

Chief Medical Officer

CIK

0001997809

Roles

Officer

Transaction Details

Transaction Date

2025-10-18

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

36,714

Footnotes

Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. | Includes 4,152 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 30, 2025. | This sale was made to cover withholding taxes following the vesting of previously granted RSUs pursuant to a durable automatic sale instruction letter adopted by Dr. Brooks on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Brooks. | The RSUs were granted on October 18, 2023 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

Filing Info

Accession No.

0001193125-25-245090

Form Type

4

Issuer CIK

0001707502

Brooks Gabriel's History

Date Ticker Type Value
2026-01-29 SLDB A $0
2025-10-20 SLDB $17K
2025-10-18 SLDB M
2025-10-18 SLDB M $0
2025-08-14 SLDB A $0
2025-08-14 SLDB A $0

Other Insiders at SLDB (90d)

Insider Bought Sold Last
SMITH IAN F 2026-04-02
Howton David T
Chief Operating Officer
2026-01-29
Cumbo Alexander
President and CEO
2026-01-29
Tan Kevin
CFO & Treasurer
2026-01-29
Hanrahan Jessie
Chief Regulatory Officer
2026-01-29
Herzich Paul
Chief Technology Officer
2026-01-29
Brooks Gabriel
Chief Medical Officer
2026-01-29